Bortezomib modulates CHIT1 and YKL40 in monocyte-derived osteoclast and in myeloma cells.
Tibullo D, Di Rosa M, Giallongo C, La Cava P, Parrinello NL, Romano A, Conticello C, Brundo MV, Saccone S, Malaguarnera L, Di Raimondo F.
Tibullo D, et al. Among authors: di raimondo f, di rosa m.
Front Pharmacol. 2015 Oct 14;6:226. doi: 10.3389/fphar.2015.00226. eCollection 2015.
Front Pharmacol. 2015.
PMID: 26528182
Free PMC article.